Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RB1 Gene Mutation”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Early research (Phase 1)Looking for participantsNCT06577987
What this trial is testing

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorRefractory Solid Tumor+7 more
Circle Pharma 220
Testing effectiveness (Phase 2)UnknownNCT04690725
What this trial is testing

TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN Loss

Who this might be right for
Safety IssuesEfficacy, Self
Peking University People's Hospital 29
Testing effectiveness (Phase 2)Study completedNCT03190174
What this trial is testing

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Who this might be right for
Ewing SarcomaPEComaEpithelioid Sarcoma+11 more
Sarcoma Oncology Research Center, LLC 34
Not applicableStudy completedNCT04956198
What this trial is testing

Drug Sensitivity and Mutation Profiling

Who this might be right for
Ewing SarcomaOsteosarcomaRhabdomyosarcoma+4 more
Florida International University 14
Not applicableStudy completedNCT00342797
What this trial is testing

Retinoblastoma Biomarker Study

Who this might be right for
RetinoblastomaMelanomaSarcoma
National Cancer Institute (NCI) 2,136
Testing effectiveness (Phase 2)Study completedNCT03213665
What this trial is testing

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Non-Hodgkin Lymphoma+38 more
National Cancer Institute (NCI) 20
Not applicableStudy completedNCT03997747
What this trial is testing

Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OS

Who this might be right for
Osteosarcoma
Peking University People's Hospital 38
Testing effectiveness (Phase 2)WithdrawnNCT00003273
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaRetinoblastoma+1 more
NYU Langone Health
Not applicableStudy completedNCT04452292
What this trial is testing

Next Generation Sequencing-Based Stratification of Front Line Treatment of HighGrade Neuroendocrine Carcinoma

Who this might be right for
Large-Cell Neuroendocrine Carcinoma
Charles Kunos 2